Title : Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.

Pub. Date : 2018

PMID : 29298347






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The BH3-only apoptosis agonists BAD and NOXA target BCL-2 and MCL-1 respectively and co-operate to induce apoptosis. BH 3 MCL1 apoptosis regulator, BCL2 family member Homo sapiens
2 We found that a broad range of anti-leukaemic agents-notably MCL-1 inhibitors, DNA damaging agents and FLT3 inhibitors-sensitise leukaemia cells to BAD-BH3. BH 3 MCL1 apoptosis regulator, BCL2 family member Homo sapiens
3 In conclusion, dynamic BH3 profiling is a useful mechanism-based tool for understanding and predicting co-operative lethality between drugs sensitising to BCL-2 antagonism and drugs sensitising to MCL-1 antagonism. BH 3 MCL1 apoptosis regulator, BCL2 family member Homo sapiens